Cargando…
What matters to people with memory problems, healthy volunteers and health and social care professionals in the context of developing treatment to prevent Alzheimer's dementia? A qualitative study
BACKGROUND: Alzheimer's disease (AD) is recognized as one of the greatest global public health challenges. There is increasing consensus that optimal disease modification using pharmaceuticals may best be achieved earlier in the disease continuum before symptoms occur. However, more needs to be...
Autores principales: | Watson, Julie, Saunders, Stina, Muniz Terrera, Graciela, Ritchie, Craig, Evans, Alison, Luz, Saturnino, Clarke, Charlotte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543163/ https://www.ncbi.nlm.nih.gov/pubmed/30809895 http://dx.doi.org/10.1111/hex.12876 |
Ejemplares similares
-
Participant outcomes and preferences in Alzheimer's disease clinical trials: The electronic Person-Specific Outcome Measure (ePSOM) development program
por: Saunders, Stina, et al.
Publicado: (2018) -
Application of Big Data and Artificial Intelligence technologies to dementia prevention research: an opportunity for low-and-middle-income countries
por: Danso, Samuel O, et al.
Publicado: (2019) -
Dementia trials and dementia tribulations: methodological and analytical challenges in dementia research
por: Ritchie, Craig W, et al.
Publicado: (2015) -
Correction to: Assessing and disclosing test results for ‘mild cognitive impairment’: the perspective of old age psychiatrists in Scotland
por: Saunders, Stina, et al.
Publicado: (2022) -
Assessing and disclosing test results for ‘mild cognitive impairment’: the perspective of old age psychiatrists in Scotland
por: Saunders, Stina, et al.
Publicado: (2022)